Welcome : Guest

Bio Time, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Bio Time, Inc., which is principally a Clinical-Stage Biopharmaceutical Company. Illustrated with 117 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-31377
Price: $3500
Company Type: Public
Pages: 123
Date: February 2017
Market Data Tables: 117

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: BioTime, Inc.’s Revenues by Category Worldwide (2014-2015) in Percentage for Subscription and advertisement Revenues, Royalties from Product Sales, Grant Income, and Sale of Research Products and Services......6
Table 2: BioTime, Inc.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for USA, and Asia......7
Biotechnology......8
Table 3: Biotechnology Market by Category in China (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......8
Table 4: Biotechnology Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......9
Biotesting (Outsourced)......10
Table 5: Outsourced Biotesting Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Environment, Pharma and Others......10
Biotechnology Drugs......11
Table 6: Biotechnology Drugs by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Cell Therapy, Gene Therapy, Monoclonal Antibodies (MAB), Recombinant Hormones and Proteins, Vaccines, and Others......11
Stem Cell Transplantation......12
Table 7: Stem Cell Transplantation Market by Category for American Indian and Alaskan Natives in the US (2015) - Percentage Market Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......12
Table 8: Stem Cell Transplantation Market by Category for Asians in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......13
Table 9: Stem Cell Transplant Market by Category for Black and African Americans in the US (2015) - Percentage Market Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......14
Table 10: Stem Cell Transplantation Market by Category for Native Hawalian and Other Pacific Islanders in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......15
Table 11: Stem Cell Transplantation Market by Category for Whites in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......16
Surgery Market......17
Table 12: Analogic Ultrasound Market for Surgery by Company Worldwide (2014) - Percentage Share Breakdown by Value Sales for Analogic Corporation, GE Medical Systems Ltd., Hitachi-Aloka Medical Ltd., Siemens Corporation, and Others......17
Table 13: General Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for < 15 Years, 15-44 Years, 45-64 Years, and 65+ Years......18
Table 14: Surgery Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Bariatric Surgery, Colorectal Surgery, General Surgery, Gynecology/Urology Surgery, and Thoracic Surgery......19
Surgical Procedures......20
Table 15: Surgical Procedures Market by Type in the US (2015) - Percentage Breakdown by Volume for Cardiac, Colon and Rectal, Ears, Nose, and Throat (ENT), General Surgery, Gynecology (GYN), Thoracis and Urology......20
Table 16: Cosmetic Surgical Procedures Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Breast Augmentation, Eyelid Surgery, Facelift, Liposuction, Nose Reshaping, and Others......21
Breast Surgery......22
Table 17: Breast Surgery by Procedures Worldwide (2015) - Percentage Market Share Breakdown by Volume for Breast Augmentation (Augmentation Mammoplasty), Breast Implant Removals (Augmentation Patients Only), Breast Lift (Mastopexy), Breast Reduction (Aesthetic Patients Only), and Breast Reduction in Men (Gynecomastia)......22
Cardiac Surgery......23
Table 18: Cardiac Surgery Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Emergency Room, Home Health, In Patient Hospital, Office Based, Out Patient Hospital, Prescription Drugs......23
Cardiothoracic Surgery......24
Table 19: Cardiothoracic Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for 45-64 Years and 65+ Years......24
Cataract Surgeries......25
Table 20: Cataract Surgeries Market in China (2015-2020) in RMB Million......25
Excimer Surgeries......26
Table 21: Excimer Surgeries Market in China (2015-2020) in RMB Million......26
Table 22: Number of Excimer Surgeries in China (2015-2020) in '000......27
Inpatient Surgery......28
Table 23: Inpatient Surgery Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Cardiovascular, Digestive, Eye, Integumentary, Musculoskeletal, and Others......28
Ophthalmology Surgery......29
Table 24: Ophthalmology Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for 45-64 Years, 65+ Years Age, and Others......29
Orthopaedic Surgery......30
Table 25: Orthopaedic Surgery Market by Payer US (2015) - Percentage Share Breakdown by Value for Medicaid, Medicare, Private, Uninsured, and Others......30
Table 26: Orthopedic Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for 15-44 Years, 45-64 Years, and 65+ Years......31
Otolaryngology Surgery......32
Table 27: Otolaryngology Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for < 15 years, 15-44 Years, 45-64 Years, and 65+ Years......32
Spine Surgery......33
Table 28: Spine Surgery Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Allografts, Anterior Cervical Plate, Anterior Lumbar Interbody Fusion, Anterior Lumbar Plates, Balloon Kyphoplasty, Bone Morphogenetic Proteins, Cervical Artificial Discs, Demineralised Bone Matrix, Intervertebral Spacer Systems, Lumbar Artificial Discs, Post. Pedicle Screw Fusion Systems, Posterior Lumbar Interbody Fusion, Transabd. Lumbar Interbody Fusion, and Vertebroplasty......33
Table 29: Spine Surgery Procedures by Indication in the US (2015) - Percentage Share Breakdown by Volume for Severe Scoliosis, Spondylolisthesis (Lumbar Region), Trauma, and Tumours......34
Urology Surgery......35
Table 30: Urology Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for < 15 years, 15-44 Years, 45-64 Years, and 65+ Years......35
Ambulatory Surgery Center......36
Table 31: Ambulatory Surgery Center Market by Speciality Type in the US (2015) - Percentage Share Breakdown by Value Sales for Dermatology, Gastrointestinal, Multispecialty, Ophthalmology, Orthopedics, Pain Management, and Others......36
Surgical Instruments......37
Table 32: Surgical Instruments Market by Category in the US (2015) - Percentage Share Breakdown by Volume Sales for Bariatric Surgery, Colorectal Surgery, General Surgery, GYN, Urology, and Thoracic Surgery......37
Surgical Specialties......38
Table 33: Surgical Specialties Market by Product Segment Worldwide (2015) - Percentage Breakdown by Value for Breast Reconstruction, Gronian Hernia, Hemostatis, Hernia Fixation, Performance of Irrigation, and Ventral Hernia......38
Table 34: Physician Market for Surgical Specialty Sector by Category in the US (2015) - Percentage Share Breakdown by No. of patients for General Surgery, Obstetrics and Gynecology, Ophthalmology, Orthopedic Surgery, Otolaryngology, Urology, and Others......39
Blood Market......40
Table 35: Blood Market by Product Worldwide (2015) - Percentage Share Breakdown by Volume for White Blood Cells, Red Blood Cells and Blood Plasma......40
Table 36: Automated Whole Blood Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for United States and Developed World......41
Blood Products......42
Table 37: Blood Products Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for China, France, Germany, Japan, Latin America, United Kingdom, United States, and Others......42
Table 38: Blood Products Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Albumin, Immunoglobins (Antibodies), Red Blood Cells, and Others......43
Table 39: Blood Products Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Blood Therapeutics, Blood Typing & Screening Products, and Blood Processing Equipment & Associated Products......44
Blood Gas Analysers......45
Table 40: Blood Gas Analyser Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Accessories, Instruments, Quality Control, Samplers, and Services......45
Table 41: Blood Gas Analyser Market by Application Worldwide (2015) - Percentage Share Breakdown by Value for Accessories, Instruments, Quality Control, Samplers, and Services......46
Bone Graft Substitutes......47
Table 42: Bone Graft Substitute Market by Category in the US (2015) - Percentage Share Breakdown by Value for Bone Morphogenetic Protein (BMP), Cell-based Matrices, Demineralized Bone Matrix (DBM) Gel, Demineralized Bone Matrix (DBM) Putty, and Synthetic Bone Graft Substitute (BGS)......47
Table 43: Bone Graft Substitute Market in the US (2015) in Million US$......48
Cancer Drugs......49
Table 44: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......49
Table 45: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......50
Cancer Market......51
Table 46: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......51
Table 47: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......52
Table 48: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......53
Table 49: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......54
Table 50: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......55
Table 51: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......56
Table 52: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......57
Table 53: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......58
Cancer Patients......59
Table 54: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......59
Table 55: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......60
Table 56: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......61
Table 57: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......62
Table 58: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......63
Table 59: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......64
Table 60: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......65
Table 61: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......66
Table 62: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......67
Table 63: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......68
Table 64: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......69
Table 65: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......70
Table 66: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......71
Table 67: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......72
Table 68: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......73
Table 69: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......74
Table 70: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......75
Table 71: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......76
Table 72: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......77
Table 73: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......78
Table 74: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......79
Cervical Cancer......80
Table 75: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......80
Table 76: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......81
Hematological Cancer......82
Table 77: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......82
Skin Cancer......83
Table 78: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......83
Cancer-Associated Mucositis......84
Table 79: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......84
Chronic Myelogenous Leukemia (CML)......85
Table 80: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......85
Multiple Myeloma......86
Table 81: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......86
Table 82: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......87
Oncology Genomics......88
Table 83: Oncology Genomics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......88
Table 84: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......89
Table 85: Oncology Genomics Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......90
Biotechnology......91
Table 86: Market Shares of Leading Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Value for Amgen, Inc., Merck KGaA, Monsanto Company, Roche Holding AG, Syngenta AG, and Others......91
Table 87: Market Shares of Leading Agricultural Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Research and Development (R&D) Expenditure for Bayer CropScience AG, Dow AgroSciences LLC, DuPont Pioneer, Monsanto Co., Inc., Syngenta AG and Others......92
Table 88: Market Shares of Leading Biotechnology Companies in China (2015) - Percentage Share Breakdown by Value for F. Hoffmann-La Roche Ltd., MERCK SERONO CO., LTD., Novo Nordisk A/S, Qilu Pharmaceutical Co., Ltd. and Others......93
Outsourced Biotesting......94
Table 89: Market Shares of Leading Outsourced Biotesting Companies Worldwide (2015) - Percentage Share Breakdown by Value for Eurofins Scientific, SGS S.A. and Others......94
Colony-Stimulating Factor (GCSF)......95
Table 90: Market Shares of Leading Granulocyte Colony-Stimulating Factor (GCSF) Companies in China (2014) - Percentage Share Breakdown by Value for Amoytop Biotech Co., Ltd., Harbin Pharmaceutical Group Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Qilu pharmaceutical Co., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd., and Others......95
Radiation Oncology Equipment......96
Table 91: Market Shares of Leading Radiation Oncology Equipment Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Elekta, Siemens AG, Varian Medical Systems and Others......96
Surgical Endoscope Equipment......97
Table 92: Market Shares of Leading Surgical Endoscope Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Karl Storz GmbH & Co. KG, Olympus Corporation, Stryker Corporation and Others......97
Surgical Energy Devices......98
Table 93: Market Shares of Leading Surgical Energy Device Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Covidien Ltd., Olympus Corporation and Others......98
Surgical Instruments......99
Table 94: Market Shares of Leading Surgical Instrument Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Applied Biosystems, Covidien Public Limited Company, Johnson & Johnson, Teleflex Incorporated, and Others......99
Blood Collection Systems (Automated)......100
Table 95: Market Shares of Leading Automated Blood Collection Systems Manufacturers in Asia (2015) - Percentage Share Breakdown by Value for Fresenius SE & Co. KGaA (Fenwal, Inc.), Haemonetics Corporation (Pall Corporation), and Terumo Corporation......100
Table 96: Market Shares of Leading Automated Blood Collection Systems Manufacturers in Europe (2015) - Percentage Share Breakdown by Value for Fresenius SE & Co. KGaA (Fenwal, Inc.), Haemonetics Corporation (Pall Corporation), Terumo Corporation, and Others......101
Table 97: Market Shares of Leading Automated Blood Collection Systems Manufacturers in Japan (2015) - Percentage Share Breakdown by Value for Haemonetics Corporation (Pall Corporation), and Terumo Corporation......102
Table 98: Market Shares of Leading Automated Blood Collection Systems Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Fresenius SE & Co. KGaA (Fenwal, Inc.), Haemonetics Corporation (Pall Corporation), and Terumo Corporation......103
Blood Collection Systems (Whole)......104
Table 99: Market Shares of Leading Whole Blood Collection Systems Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Fenwal, Inc., Fresenius SE & Co, Haemonetics Corporation, MacoPharma, Terumo Corporation, WEGO, and Others......104
Table 100: Market Shares of Leading Whole Blood Collection Systems Manufacturers in Asia (2015) - Percentage Share Breakdown by Value for Fresenius SE & Co. KGaA (Fenwal, Inc.), Haemonetics Corporation (Pall Corporation), Shandong Weigao Group Medical Polymer Co., Ltd., Terumo Corporation, and Others......105
Table 101: Market Shares of Leading Whole Blood Collection Systems Manufacturers in Europe (2015) - Percentage Share Breakdown by Value for Fresenius SE & Co. KGaA (Fenwal, Inc.), Macopharma SA, Terumo Corporation, and Others......106
Table 102: Market Shares of Leading Whole Blood Collection Systems Manufacturers in Japan (2015) - Percentage Share Breakdown by Value for Kawasumi Laboratories, Inc., and Terumo Corporation......107
Table 103: Market Shares of Leading Whole Blood Collection Systems Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for HemeXcel, The American National Red Cross, and Others......108
Table 104: Market Shares of Leading Whole Blood Collection Systems Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Fresenius SE & Co. KGaA, Haemonetics Corporation (Pall Corporation), and Others......109
Blood Collection Tubes......110
Table 105: Market Shares of Leading Blood Collection Tube Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Becton, Dickinson and Company (BDX), Covidien Plc (COV), Terumo Corporation, and Others......110
Table 106: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......111
Table 107: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......112
Table 108: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......113
Table 109: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......114
Table 110: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......115
Breast Cancer Drugs......116
Table 111: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......116
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......117
Table 112: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......117
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......118
Table 113: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......118
Table 114: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......119
Table 115: BioTime, Inc.’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for U.S. and Asia......120
Table 116: BioTime, Inc.’s Sales by Geographic Region Worldwide (2013) in Percentage for Domestic and Asia......121
Table 117: BioTime, Inc.’s Revenues by Category Worldwide (2013) in Percentage for License Fees, Royalties from Product Sales, Grant Income and Sales of Research Products......122